NCT02740543View on ClinicalTrials.gov

Biomarkers of Irritant-Induced and Allergic Asthma

PHASE2CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

October 23, 2019

Study Completion Date

October 23, 2019

Conditions
Asthma
Interventions
DRUG

Fluticasone propionate HFA 220

Subjects will take two (2) puffs of Fluticasone propionate HFA 220 twice a day.

Trial Locations (1)

10016

New York University Langone Medical Center, New York

All Listed Sponsors
lead

NYU Langone Health

OTHER

NCT02740543 - Biomarkers of Irritant-Induced and Allergic Asthma | Biotech Hunter | Biotech Hunter